Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 568

1.

Integrated care management of patients with atrial fibrillation-far from optimal.

Pignatelli P, Violi F, Pastori D.

Pol Arch Intern Med. 2020 Mar 27;130(3):176-178. doi: 10.20452/pamw.15260. Epub 2020 Mar 27. No abstract available.

2.

Oxidative stress and gut-derived lipopolysaccharides in children affected by paediatric autoimmune neuropsychiatric disorders associated with streptococcal infections.

Loffredo L, Spalice A, Salvatori F, De Castro G, Guido CA, Zicari AM, Ciacci P, Battaglia S, Brindisi G, Ettorre E, Nocella C, Salvatori G, Duse M, Violi F, Carnevale R.

BMC Pediatr. 2020 Mar 18;20(1):127. doi: 10.1186/s12887-020-02026-8.

3.

Oxidative Stress and Gut-Derived Lipopolysaccharides in Neurodegenerative Disease: Role of NOX2.

Loffredo L, Ettorre E, Zicari AM, Inghilleri M, Nocella C, Perri L, Spalice A, Fossati C, De Lucia MC, Pigozzi F, Cacciafesta M, Violi F, Carnevale R; Neurodegenerative Disease study group .

Oxid Med Cell Longev. 2020 Jan 31;2020:8630275. doi: 10.1155/2020/8630275. eCollection 2020.

4.

Determinants of low-quality warfarin anticoagulation in patients with mechanical prosthetic heart valves. The nationwide PLECTRUM study.

Pastori D, Lip GYH, Poli D, Antonucci E, Rubino L, Menichelli D, Saliola M, Violi F, Palareti G, Pignatelli P; Italian Federation of Anticoagulation Clinics (FCSA).

Br J Haematol. 2020 Feb 20. doi: 10.1111/bjh.16528. [Epub ahead of print]

PMID:
32080833
5.

Von Willebrand and Factor VIII Portosystemic Circulation Gradient in Cirrhosis: Implications for Portal Vein Thrombosis.

Praktiknjo M, Trebicka J, Carnevale R, Pastori D, Queck A, Ettorre E, Violi F.

Clin Transl Gastroenterol. 2020 Feb;11(2):e00123. doi: 10.14309/ctg.0000000000000123.

PMID:
32032127
6.

Clinical and Lifestyle Factors and Risk of Amyotrophic Lateral Sclerosis: A Population-Based Case-Control Study.

Filippini T, Fiore M, Tesauro M, Malagoli C, Consonni M, Violi F, Arcolin E, Iacuzio L, Oliveri Conti G, Cristaldi A, Zuccarello P, Zucchi E, Mazzini L, Pisano F, Gagliardi I, Patti F, Mandrioli J, Ferrante M, Vinceti M.

Int J Environ Res Public Health. 2020 Jan 30;17(3). pii: E857. doi: 10.3390/ijerph17030857.

7.

Seronegative antiphospholipid syndrome: refining the value of "non-criteria" antibodies for diagnosis and clinical management.

Pignatelli P, Ettorre E, Menichelli D, Pani A, Violi F, Pastori D.

Haematologica. 2020 Mar;105(3):562-572. doi: 10.3324/haematol.2019.221945. Epub 2020 Jan 30. Review.

8.

Low-grade endotoxaemia enhances artery thrombus growth via Toll-like receptor 4: implication for myocardial infarction.

Carnevale R, Sciarretta S, Valenti V, di Nonno F, Calvieri C, Nocella C, Frati G, Forte M, d'Amati G, Pignataro MG, Severino A, Cangemi R, Arrivi A, Dominici M, Mangieri E, Gaudio C, Tanzilli G, Violi F.

Eur Heart J. 2020 Jan 3. pii: ehz893. doi: 10.1093/eurheartj/ehz893. [Epub ahead of print]

PMID:
31898723
9.

Nonalcoholic Fatty Liver Disease and Fibrosis Associated With Increased Risk of Cardiovascular Events in a Prospective Study.

Baratta F, Pastori D, Angelico F, Balla A, Paganini AM, Cocomello N, Ferro D, Violi F, Sanyal AJ, Del Ben M.

Clin Gastroenterol Hepatol. 2019 Dec 27. pii: S1542-3565(19)31506-X. doi: 10.1016/j.cgh.2019.12.026. [Epub ahead of print]

PMID:
31887443
10.

Increased liver localization of lipopolysaccharides in human and experimental non-alcoholic fatty liver disease.

Carpino G, Del Ben M, Pastori D, Carnevale R, Baratta F, Overi D, Francis H, Cardinale V, Onori P, Safarikia S, Cammisotto V, Alvaro D, Svegliati-Baroni G, Angelico F, Gaudio E, Violi F.

Hepatology. 2019 Dec 6. doi: 10.1002/hep.31056. [Epub ahead of print]

PMID:
31808577
11.

Prevalence and Impact of Nonalcoholic Fatty Liver Disease in Atrial Fibrillation.

Pastori D, Sciacqua A, Marcucci R, Farcomeni A, Perticone F, Del Ben M, Angelico F, Baratta F, Pignatelli P, Violi F; ATHERO-AF study group.

Mayo Clin Proc. 2020 Mar;95(3):513-520. doi: 10.1016/j.mayocp.2019.08.027. Epub 2019 Nov 18.

PMID:
31753536
12.

Multiple Arterial Thrombosis in Seronegative Antiphospholipid Syndrome: Need for New Diagnostic Criteria?

Pastori D, Misasi R, Sorice M, Cribari F, Menichelli D, Violi F, Pignatelli P.

Eur J Case Rep Intern Med. 2019 Sep 23;6(10):001180. doi: 10.12890/2019_001180. eCollection 2019.

13.

Anticoagulants in Atrial Fibrillation and Liver Disease.

Pignatelli P, Pastori D, Violi F.

J Am Coll Cardiol. 2019 Nov 12;74(19):2436. doi: 10.1016/j.jacc.2019.07.090. No abstract available.

PMID:
31699289
14.

Thrombocytopenia and Mortality Risk in Patients With Atrial Fibrillation: An Analysis From the START Registry.

Pastori D, Antonucci E, Violi F, Palareti G, Pignatelli P; START2 Registry Investigators ‡; START2 Registry Investigators <xref ref-type="author-note" rid="jah34460-note-1002"><sup>‡</sup></xref>.

J Am Heart Assoc. 2019 Nov 5;8(21):e012596. doi: 10.1161/JAHA.119.012596. Epub 2019 Oct 28.

15.

Amyotrophic lateral sclerosis incidence following exposure to inorganic selenium in drinking water: A long-term follow-up.

Vinceti M, Filippini T, Malagoli C, Violi F, Mandrioli J, Consonni D, Rothman KJ, Wise LA.

Environ Res. 2019 Dec;179(Pt A):108742. doi: 10.1016/j.envres.2019.108742. Epub 2019 Sep 14.

PMID:
31629180
16.

Clinical Cirrhosis Dilemmas: Survey of Practice from the 7th International Coagulation in Liver Disease Conference.

Stine JG, Intagliata NM, Shah NL, Lisman T, Violi F, Caldwell SH, Argo CK.

Dig Dis Sci. 2019 Oct 18. doi: 10.1007/s10620-019-05884-0. [Epub ahead of print]

PMID:
31628574
17.

Serum albumin and risk of cardiovascular events in primary and secondary prevention: a systematic review of observational studies and Bayesian meta-regression analysis.

Pignatelli P, Farcomeni A, Menichelli D, Pastori D, Violi F.

Intern Emerg Med. 2020 Jan;15(1):135-143. doi: 10.1007/s11739-019-02204-2. Epub 2019 Oct 11. Review.

PMID:
31605272
18.

Oleuropein-enriched chocolate by extra virgin olive oil blunts hyperglycaemia in diabetic patients: Results from a one-time 2-hour post-prandial cross over study.

Del Ben M, Nocella C, Loffredo L, Bartimoccia S, Cammisotto V, Mancinella M, Angelico F, Valenti V, Cavarretta E, Carnevale R, Violi F.

Clin Nutr. 2019 Sep 21. pii: S0261-5614(19)33066-3. doi: 10.1016/j.clnu.2019.09.006. [Epub ahead of print]

PMID:
31585740
19.

Environment and health: Risk perception and its determinants among Italian university students.

Carducci A, Fiore M, Azara A, Bonaccorsi G, Bortoletto M, Caggiano G, Calamusa A, De Donno A, De Giglio O, Dettori M, Di Giovanni P, Di Pietro A, Facciolà A, Federigi I, Grappasonni I, Izzotti A, Libralato G, Lorini C, Montagna MT, Nicolosi LK, Paladino G, Palomba G, Petrelli F, Schilirò T, Scuri S, Serio F, Tesauro M, Verani M, Vinceti M, Violi F, Ferrante M.

Sci Total Environ. 2019 Nov 15;691:1162-1172. doi: 10.1016/j.scitotenv.2019.07.201. Epub 2019 Jul 16.

20.

Reduced lysosomal acid lipase activity: A new marker of liver disease severity across the clinical continuum of non-alcoholic fatty liver disease?

Baratta F, Pastori D, Ferro D, Carluccio G, Tozzi G, Angelico F, Violi F, Del Ben M.

World J Gastroenterol. 2019 Aug 14;25(30):4172-4180. doi: 10.3748/wjg.v25.i30.4172. Review.

21.

Lysosomal acid lipase activity and liver fibrosis in the clinical continuum of non-alcoholic fatty liver disease.

Baratta F, Pastori D, Tozzi G, D'Erasmo L, Di Costanzo A, Arca M, Ettorre E, Ginanni Corradini S, Violi F, Angelico F, Del Ben M.

Liver Int. 2019 Dec;39(12):2301-2308. doi: 10.1111/liv.14206. Epub 2019 Aug 21.

PMID:
31392821
22.

Interaction between serum endotoxemia and proprotein convertase subtilisin/kexin 9 (PCSK9) in patients with atrial fibrillation: A post-hoc analysis from the ATHERO-AF cohort.

Pastori D, Ettorre E, Carnevale R, Nocella C, Bartimoccia S, Del Sordo E, Cammisotto V, Violi F, Pignatelli P; Atherosclerosis in Atrial Fibrillation (ATHERO-AF) Study Group.

Atherosclerosis. 2019 Oct;289:195-200. doi: 10.1016/j.atherosclerosis.2019.07.002. Epub 2019 Jul 4.

PMID:
31303312
23.

Role of portal venous platelet activation in patients with decompensated cirrhosis and TIPS.

Queck A, Carnevale R, Uschner FE, Schierwagen R, Klein S, Jansen C, Meyer C, Praktiknjo M, Thomas D, Strassburg C, Zeuzem S, Violi F, Trebicka J.

Gut. 2019 Jul 3. pii: gutjnl-2019-319044. doi: 10.1136/gutjnl-2019-319044. [Epub ahead of print] No abstract available.

24.

Left Atrium Dilatation and Left Ventricular Hypertrophy Predispose to Atrial Fibrillation in Patients With Community-Acquired Pneumonia.

Cangemi R, Calvieri C, Taliani G, Pignatelli P, Morelli S, Falcone M, Pastori D, Violi F; SIXTUS study group.

Am J Cardiol. 2019 Sep 1;124(5):723-728. doi: 10.1016/j.amjcard.2019.05.051. Epub 2019 Jun 6.

PMID:
31266594
25.

Anti-D4GDI antibodies activate platelets in vitro: a possible link with thrombocytopenia in primary antiphospholipid syndrome.

Barbati C, Stefanini L, Colasanti T, Cipriano E, Celia A, Gabriele G, Vomero M, Ceccarelli F, Spinelli FR, Finucci A, Speziali M, Orso G, Margiotta DPE, Conti F, Violi F, Afeltra A, Valesini G, Alessandri C.

Arthritis Res Ther. 2019 Jul 1;21(1):161. doi: 10.1186/s13075-019-1947-2.

26.

Does the Coexistence of Chronic Obstructive Pulmonary Disease and Atrial Fibrillation Affect Nox2 Activity and Urinary Isoprostanes Excretion?

Pastori D, Andreozzi P, Carnevale R, Bartimoccia S, Limaj S, Melandri S, Brunori M, Spallacci G, Violi F, Pignatelli P.

Antioxid Redox Signal. 2019 Oct 10;31(11):786-790. doi: 10.1089/ars.2019.7811. Epub 2019 Jul 23.

PMID:
31250672
27.

Real-world efficacy and safety of non-vitamin K antagonist oral anticoagulants in patients with atrial fibrillation.

Violi F, Pastori D.

Intern Emerg Med. 2019 Nov;14(8):1199-1201. doi: 10.1007/s11739-019-02135-y. Epub 2019 Jun 27. No abstract available.

PMID:
31250259
28.

Effect of corticosteroids on myocardial injury among patients hospitalized for community-acquired pneumonia: rationale and study design. The colosseum trial.

Violi F, Calvieri C, Cangemi R.

Intern Emerg Med. 2020 Jan;15(1):79-86. doi: 10.1007/s11739-019-02117-0. Epub 2019 May 31.

PMID:
31152308
29.

Enhanced NOX-2 derived oxidative stress in offspring of patients with early myocardial infarction.

Loffredo L, Martino F, Zicari AM, Carnevale R, Battaglia S, Martino E, Cammisotto V, Peruzzi M, De Castro G, Duse M, Barillà F, Violi F.

Int J Cardiol. 2019 Oct 15;293:56-59. doi: 10.1016/j.ijcard.2019.05.014. Epub 2019 May 7.

PMID:
31126732
30.

Alirocumab after Acute Coronary Syndrome.

Pignatelli P, Camera M, Violi F.

N Engl J Med. 2019 May 23;380(21):2076. doi: 10.1056/NEJMc1902955. No abstract available.

PMID:
31116933
31.

Relationship of Antiphospholipid Antibodies to Risk of Dementia: A Systematic Review.

Bucci T, Menichelli D, Pignatelli P, Triggiani M, Violi F, Pastori D.

J Alzheimers Dis. 2019;69(2):561-576. doi: 10.3233/JAD-181294.

PMID:
31104025
32.

Serum Albumin Is Inversely Associated With Portal Vein Thrombosis in Cirrhosis.

Basili S, Carnevale R, Nocella C, Bartimoccia S, Raparelli V, Talerico G, Stefanini L, Romiti GF, Perticone F, Corazza GR, Piscaglia F, Pietrangelo A, Violi F; PRO‐LIVER Collaborators.

Hepatol Commun. 2019 Mar 2;3(4):504-512. doi: 10.1002/hep4.1317. eCollection 2019 Apr.

33.

Tailored Practical Management of Patients With Atrial Fibrillation: A Risk Factor-Based Approach.

Pastori D, Menichelli D, Gingis R, Pignatelli P, Violi F.

Front Cardiovasc Med. 2019 Mar 12;6:17. doi: 10.3389/fcvm.2019.00017. eCollection 2019. Review.

34.

Update and Unmet Needs on the Use of Nonvitamin K Oral Anticoagulants for Stroke Prevention in Patients With Atrial Fibrillation.

Menichelli D, Ettorre E, Pani A, Violi F, Pignatelli P, Pastori D.

Curr Probl Cardiol. 2019 Feb 27:100410. doi: 10.1016/j.cpcardiol.2019.02.002. [Epub ahead of print] Review.

PMID:
30904157
35.

Acute Effects of Heat-Not-Burn, Electronic Vaping, and Traditional Tobacco Combustion Cigarettes: The Sapienza University of Rome-Vascular Assessment of Proatherosclerotic Effects of Smoking ( SUR - VAPES ) 2 Randomized Trial.

Biondi-Zoccai G, Sciarretta S, Bullen C, Nocella C, Violi F, Loffredo L, Pignatelli P, Perri L, Peruzzi M, Marullo AGM, De Falco E, Chimenti I, Cammisotto V, Valenti V, Coluzzi F, Cavarretta E, Carrizzo A, Prati F, Carnevale R, Frati G.

J Am Heart Assoc. 2019 Mar 19;8(6):e010455. doi: 10.1161/JAHA.118.010455.

36.

Immunoglobulin G (IgG) anticardiolipin antibodies and recurrent cardiovascular events. A systematic review and Bayesian meta-regression analysis.

Pastori D, Bucci T, Triggiani M, Ames PRJ, Parrotto S, Violi F, Pignatelli P, Farcomeni A.

Autoimmun Rev. 2019 May;18(5):519-525. doi: 10.1016/j.autrev.2019.03.005. Epub 2019 Mar 4.

PMID:
30844560
37.

Nox2-mediated platelet activation by glycoprotein (GP) VI: Effect of rivaroxaban alone and in combination with aspirin.

Cammisotto V, Carnevale R, Nocella C, Stefanini L, Bartimoccia S, Coluccia A, Silvestri R, Pignatelli P, Pastori D, Violi F.

Biochem Pharmacol. 2019 May;163:111-118. doi: 10.1016/j.bcp.2019.02.016. Epub 2019 Feb 13.

PMID:
30771281
38.

Collagen type IV remodelling gender-specifically predicts mortality in decompensated cirrhosis.

Lehmann J, Praktiknjo M, Nielsen MJ, Schierwagen R, Meyer C, Thomas D, Violi F, Strassburg CP, Bendtsen F, Møller S, Krag A, Karsdal MA, Leeming DJ, Trebicka J.

Liver Int. 2019 May;39(5):885-893. doi: 10.1111/liv.14070. Epub 2019 Mar 7.

39.

Aluminum and tin: Food contamination and dietary intake in an Italian population.

Filippini T, Tancredi S, Malagoli C, Cilloni S, Malavolti M, Violi F, Vescovi L, Bargellini A, Vinceti M.

J Trace Elem Med Biol. 2019 Mar;52:293-301. doi: 10.1016/j.jtemb.2019.01.012. Epub 2019 Jan 23.

PMID:
30732896
40.

Management of Patients with Asymptomatic and Symptomatic Carotid Artery Disease: Update on Anti-Thrombotic Therapy.

Pastori D, Eikelboom JW, Anand SS, Patel MR, Tanguay JF, Ricco JB, Debus ES, Mazzolai L, Bauersachs R, Verhamme P, Bosch J, Nikol S, Nehler M, Aboyans V, Violi F.

Thromb Haemost. 2019 Apr;119(4):576-585. doi: 10.1055/s-0039-1678527. Epub 2019 Jan 31. Review.

PMID:
30703812
41.

ABC (Atrial fibrillation Better Care) Pathway and Healthcare Costs in Atrial Fibrillation: The ATHERO-AF Study.

Pastori D, Farcomeni A, Pignatelli P, Violi F, Lip GY.

Am J Med. 2019 Jul;132(7):856-861. doi: 10.1016/j.amjmed.2019.01.003. Epub 2019 Jan 16.

PMID:
30659810
42.

Incidence and Recurrence of Portal Vein Thrombosis in Cirrhotic Patients.

Violi F, Corazza GR, Caldwell SH, Talerico G, Romiti GF, Napoleone L, Perticone F, Bolondi L, Pietrangelo A, Vestri AR, Raparelli V, Basili S; PRO-LIVER Collaborative Group.

Thromb Haemost. 2019 Mar;119(3):496-499. doi: 10.1055/s-0038-1676981. Epub 2019 Jan 7.

PMID:
30616246
43.

Low Rate of Intrahospital Deep Venous Thrombosis in Acutely Ill Medical Patients: Results From the AURELIO Study.

Loffredo L, Arienti V, Vidili G, Cogliati C, Battaglia S, Perri L, Di Giulio R, Bernardini S, Summa ML, Sciacqua A, Perticone F, Boddi M, Di Minno G, Lodigiani C, Pietrangelo A, Farcomeni A, Violi F; AURELIO Study Group.

Mayo Clin Proc. 2019 Jan;94(1):37-43. doi: 10.1016/j.mayocp.2018.07.020.

PMID:
30611451
44.

Atrial fibrillation and human immunodeficiency virus type-1 infection: a systematic review. Implications for anticoagulant and antiarrhythmic therapy.

Pastori D, Mezzaroma I, Pignatelli P, Violi F, Lip GYH.

Br J Clin Pharmacol. 2019 Mar;85(3):508-515. doi: 10.1111/bcp.13837. Epub 2019 Jan 11.

45.

Digoxin and Platelet Activation in Patients With Atrial Fibrillation: In Vivo and In Vitro Study.

Pastori D, Carnevale R, Nocella C, Bartimoccia S, Novo M, Cammisotto V, Piconese S, Santulli M, Vasaturo F, Violi F, Pignatelli P; Atherosclerosis in Atrial Fibrillation (ATHERO‐AF) Study Group.

J Am Heart Assoc. 2018 Nov 20;7(22):e009509. doi: 10.1161/JAHA.118.009509.

46.

Integrated Care Management of Patients With Atrial Fibrillation and Risk of Cardiovascular Events: The ABC (Atrial fibrillation Better Care) Pathway in the ATHERO-AF Study Cohort.

Pastori D, Pignatelli P, Menichelli D, Violi F, Lip GYH.

Mayo Clin Proc. 2019 Jul;94(7):1261-1267. doi: 10.1016/j.mayocp.2018.10.022. Epub 2018 Dec 11.

PMID:
30551910
47.

A Hypothesis-Generating Study of the Combination of Aspirin plus Macrolides in Patients with Severe Community-Acquired Pneumonia.

Falcone M, Russo A, Shindo Y, Farcomeni A, Pieralli F, Cangemi R, Liu J, Xia J, Okumura J, Sano M, Jones C, Vannucchi V, Mancone M, Micek S, Xu F, Violi F, Kollef M.

Antimicrob Agents Chemother. 2019 Jan 29;63(2). pii: e01556-18. doi: 10.1128/AAC.01556-18. Print 2019 Feb.

48.

Remnant Lipoprotein Cholesterol and Cardiovascular and Cerebrovascular Events in Patients with Non-Alcoholic Fatty Liver Disease.

Pastori D, Baratta F, Novo M, Cocomello N, Violi F, Angelico F, Del Ben M.

J Clin Med. 2018 Oct 23;7(11). pii: E378. doi: 10.3390/jcm7110378.

49.

Blood Hormones and Venous Thromboembolic Events: Lack of Association or Lack of Standardization?

Pastori D, Violi F.

Thromb Haemost. 2018 Nov;118(11):1847-1849. doi: 10.1055/s-0038-1675176. Epub 2018 Oct 12.

PMID:
30312977
50.

Anticoagulant therapy in patients with liver cirrhosis and portal vein thrombosis: insights for the clinician.

Basili S, Pastori D, Raparelli V, Violi F.

Therap Adv Gastroenterol. 2018 Sep 6;11:1756284818793561. doi: 10.1177/1756284818793561. eCollection 2018. Review.

Supplemental Content

Support Center